Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-09-004462
Filing Date
2009-03-27
Accepted
2009-03-27 15:56:21
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c82754e10vk.htm 10-K 600085
2 EXHIBIT 21.1 c82754exv21w1.htm EX-21.1 658
3 EXHIBIT 31.1 c82754exv31w1.htm EX-31.1 8439
4 EXHIBIT 31.2 c82754exv31w2.htm EX-31.2 8406
5 EXHIBIT 32.1 c82754exv32w1.htm EX-32.1 2360
6 EXHIBIT 32.2 c82754exv32w2.htm EX-32.2 2329
  Complete submission text file 0001362310-09-004462.txt   623787
Mailing Address 100 N. FAIRWAY DRIVE SUITE 134 VERNON HILLS IL 60061
Business Address 100 N. FAIRWAY DRIVE SUITE 134 VERNON HILLS IL 60061 847-362-8200
Winston Pharmaceuticals, Inc. (Filer) CIK: 0001302554 (see all company filings)

EIN.: 300132755 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51314 | Film No.: 09710372
SIC: 2834 Pharmaceutical Preparations